ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares
SINGAPORE, June 30, 2026 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology...
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that the FiberSense...
diaTribe Convenes International Consensus to Guide Diabetes Technology Use During Pregnancy
Expert recommendations provide crucial guidance to leverage CGM and AID during pregnancy. SAN FRANCISCO, Jan. 13, 2026 /PRNewswire/ -- The diaTribe Foundation announces the publication of the first international consensus statement on the use of...